Venture capital & private equity
From seed funding rounds to larger institutional syndicated investments
Venture Capital & Private Equity experts
Our specialist Venture Capital & Private Equity team supports VCT, EIS and other venture capital funds, private equity investors, individual angels, founders, management teams and academics on equity fundraising transactions.
We aim to build lasting relationships with our clients and to deliver quick and effective advice for scaling and high growth companies, and their investors, which is matched by clear, transparent fee arrangements.
The team, backed by specialist colleagues in our full-service firm, is proud to support the commercialisation of world-class ideas and has particular expertise acting for university spin-out companies from the University of Oxford and the University of Bristol.
We also deliver commercially focussed, pragmatic advice to both investors and management teams on private equity investments and buy-outs, and work with a variety of private equity backed portfolio companies.
.
Reflecting our commitment to supporting EIS investors and growing businesses taking on EIS investment by bringing together experts from across our firm and external networks. We carefully select the right specialists to deliver the right results for you. Our expert lawyers have transacted on hundreds of millions worth of EIS investments.
Our team have supported investors and funds such as:
Acting for Augmentum Fintech, SBI Investment and Volution on their investments into category-leading digital mortgage broker Habito.
Advising market leading investors BGF and Parkwalk on a number of co-investments into scaling businesses, including health-tech scale-up as part of an $20 million funding round.
Bregal Capital on several transactions, including the acquisition of Ideal Stelrad, the UK based manufacturer of boilers and radiators and the acquisition and subsequent reorganization of the FiveTen Group.
Rockpool Investments on various transactions, including the sale of Hartley Botanic, a luxury greenhouse manufacturer, to Alcuin Capital Partners; its investment in Rosetta Brands, an Amazon e-commerce-as-a-service provider; its investment in Oxford Online Pharmacy and the sale of Alchemist, a learning and development business, to Horizon Capital.
Our recent management-side experience includes:
Advising the founders and management team of Hybrid Media, a global digital marketing agency, on the terms of a £13m investment by LDC.
Advising Oxford Genetics (trading as OXGENETM), an Oxford based biotechnology business which specialises in biological drug development, on various investment rounds including a £6.5 million syndicated investment.
Advising the management team of Cellmark Forensic Services, a national provider of specialist forensic and DNA testing services, on the management buyout of the company.
Advising the management team of Argosy Components, a specialist supplier to the broadcast and communications industries, on the management buyout of the company.
Advising the management team of business communications provider Gradwell Communications on a private equity backed management buy-in.
Our corporate services
The latest news and insights from our team
View more articles related to Corporate